A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis?

被引:56
作者
Johnson, D
Wall, SA
Mann, S
Wilkie, AOM [1 ]
机构
[1] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England
[2] Radcliffe Infirm, Dept Plast & Reconstruct Surg, Oxford OX2 6HE, England
[3] Radcliffe Infirm, Oxford Craniofacial Unit, Oxford OX2 6HE, England
[4] John Radcliffe Hosp, Dept Anaesthet, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
craniosynostosis; FGFR2; intrauterine environment; mutation; breech presentation; foetal head constraint;
D O I
10.1038/sj.ejhg.5200499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the fibroblast growth factor receptor 1, 2 and 3 (FGFR1, -2 and -3) and TWIST genes have been identified in several syndromic forms of craniosynostosis. There remains, however, a significant number of patients with non-syndromic craniosynostosis in whom no genetic cause can be identified. We describe a novel heterozygous mutation of FGFR2 (943G --> T, encoding the amino acid substitution Ala315Ser) in a girl with non-syndromic unicoronal craniosynostosis. The mutation is also present in her mother and her maternal grandfather who have mild facial asymmetry but do not have craniosynostosis. None of these individuals has the Crouzonoid appearance typically associated with FGFR2 mutations. However, the obstetric history revealed that the proband was in persistent breech presentation in utero and was delivered by Caesarean section, at which time compression of the skull was apparent. We propose that this particular FGFR2 mutation only confers a predisposition to craniosynostosis and that an additional environmental insult (in this case foetal head constraint associated with breech position) is necessary for craniosynostosis to occur. To our knowledge, this is the first report of an interaction between a weakly pathogenic mutation and intrauterine constraint, leading to craniosynostosis.
引用
收藏
页码:571 / 577
页数:7
相关论文
共 43 条
[1]   The feet in Pfeiffer's syndrome [J].
Anderson, PJ ;
Hall, CM ;
Evans, RD ;
Jones, BM ;
Hayward, RD .
JOURNAL OF CRANIOFACIAL SURGERY, 1998, 9 (01) :83-87
[2]  
[Anonymous], 1989, SCI FDN SURG TREATME
[3]   OUTLINE STRUCTURES FOR THE EXTRACELLULAR DOMAINS OF THE FIBROBLAST GROWTH-FACTOR RECEPTORS [J].
BATEMAN, A ;
CHOTHIA, C .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (12) :1068-1074
[4]   Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes [J].
Bellus, GA ;
Gaudenz, K ;
Zackai, EH ;
Clarke, LA ;
Szabo, J ;
Francomano, CA ;
Muenke, M .
NATURE GENETICS, 1996, 14 (02) :174-176
[5]  
Chun KM, 1999, AM J HUM GENET, V65, pA289
[6]   Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome [J].
Cornejo-Roldan, LR ;
Roessler, E ;
Muenke, M .
HUMAN GENETICS, 1999, 104 (05) :425-431
[7]   Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families [J].
Coulier, F ;
Pontarotti, P ;
Roubin, R ;
Hartung, H ;
Goldfarb, M ;
Birnbaum, D .
JOURNAL OF MOLECULAR EVOLUTION, 1997, 44 (01) :43-56
[8]   CLONING AND EXPRESSION OF 2 DISTINCT HIGH-AFFINITY RECEPTORS CROSS-REACTING WITH ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS [J].
DIONNE, CA ;
CRUMLEY, G ;
BELLOT, F ;
KAPLOW, JM ;
SEARFOSS, G ;
RUTA, M ;
BURGESS, WH ;
JAYE, M ;
SCHLESSINGER, J .
EMBO JOURNAL, 1990, 9 (09) :2685-2692
[9]  
Everett ET, 1999, CLEFT PALATE-CRAN J, V36, P533, DOI 10.1597/1545-1569(1999)036<0533:ANFGMI>2.3.CO
[10]  
2